| Aug 7, 2025 |
Aug 11, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
12.5
|
-106,322
|
-17.12%
|
✓
|
$13.4M |
| Jun 12, 2025 |
Jun 16, 2025 |
Xencor Inc
|
Director |
Sell |
91.3
|
+10,513
|
125.27%
|
✓
|
$29.3K |
| May 27, 2025 |
May 29, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
40.0
|
-9,613
|
-1.83%
|
✓
|
$1.2M |
| Feb 13, 2025 |
Feb 14, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
45.0
|
-5,844
|
-0.56%
|
✓
|
$681.9K |
| Feb 8, 2025 |
Feb 12, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
46.3
|
-2,274
|
-0.44%
|
✓
|
$269.2K |
| Jan 31, 2025 |
Feb 4, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
45.0
|
-2,707
|
-0.52%
|
✓
|
$414K |
| Jan 27, 2025 |
Jan 29, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
7.5
|
-146,105
|
-22.11%
|
✓
|
$21.8M |
| Sep 27, 2024 |
Oct 1, 2024 |
Xencor Inc
|
Director |
Sell |
15.0
|
-2,654
|
-24.03%
|
✓
|
$54.9K |
| Feb 13, 2024 |
Feb 15, 2024 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-2,832
|
-0.55%
|
✓
|
$376.7K |
| Feb 13, 2024 |
Feb 15, 2024 |
Xencor Inc
|
Director |
Buy |
77.5
|
+53
|
1.06%
|
✗
|
$1K |
| Feb 6, 2024 |
Feb 8, 2024 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-5,314
|
-0.52%
|
✓
|
$737.3K |
| Jan 31, 2024 |
Feb 2, 2024 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-2,707
|
-0.54%
|
✓
|
$380.8K |
| Jan 8, 2024 |
Jan 10, 2024 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
17.5
|
-167,858
|
-14.38%
|
✓
|
$22.3M |
| Aug 21, 2023 |
Aug 23, 2023 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
40.0
|
-9,328
|
-1.83%
|
✓
|
$1M |
| Feb 6, 2023 |
Feb 8, 2023 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
40.0
|
-29,044
|
-1.49%
|
✓
|
$3M |
| Jan 31, 2023 |
Feb 2, 2023 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-2,707
|
-0.58%
|
✓
|
$298K |
| Feb 7, 2022 |
Feb 9, 2022 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-10,984
|
-0.59%
|
✓
|
$884.7K |
| Feb 5, 2021 |
Feb 9, 2021 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
42.5
|
-12,888
|
-0.71%
|
✓
|
$1.5M |
| Jan 8, 2021 |
Jan 12, 2021 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
2.5
|
-308,250
|
-25.89%
|
✓
|
$34M |
| Nov 12, 2020 |
Nov 16, 2020 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,390
|
-0.76%
|
✓
|
$307.7K |
| Aug 5, 2020 |
Aug 7, 2020 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,390
|
-0.77%
|
✓
|
$403.1K |
| Apr 24, 2020 |
Apr 28, 2020 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-2,906
|
-0.66%
|
✓
|
$289K |
| Feb 7, 2020 |
Feb 11, 2020 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,248
|
-0.75%
|
✓
|
$335.7K |
| Feb 5, 2020 |
Feb 7, 2020 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
42.5
|
-9,792
|
-0.76%
|
✓
|
$1M |
| Aug 6, 2019 |
Aug 8, 2019 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
26.3
|
-80,000
|
-6.00%
|
✓
|
$7.6M |
| Feb 6, 2019 |
Feb 8, 2019 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-4,096
|
-0.97%
|
✓
|
$345K |
| Feb 4, 2019 |
Feb 6, 2019 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-7,614
|
-0.61%
|
✓
|
$671.2K |
| May 1, 2018 |
May 3, 2018 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
2.5
|
-126,832
|
-26.77%
|
✓
|
$10.2M |
| Feb 5, 2018 |
Feb 7, 2018 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
26.3
|
-110,074
|
-7.43%
|
✓
|
$8.8M |
| Jan 16, 2018 |
Jan 18, 2018 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
42.5
|
-3,750
|
-1.10%
|
✓
|
$295.8K |
| May 2, 2017 |
May 3, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
27.5
|
-21,739
|
-6.13%
|
✓
|
$1.2M |
| Apr 12, 2017 |
Apr 13, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
30.0
|
-19,596
|
-5.56%
|
✓
|
$988.1K |
| Feb 6, 2017 |
Feb 8, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,010
|
-1.19%
|
✓
|
$130K |
| Feb 3, 2017 |
Feb 6, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,125
|
-1.25%
|
✓
|
$133K |
| Jan 17, 2017 |
Jan 18, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,750
|
-1.51%
|
✓
|
$152.4K |
| Jan 10, 2017 |
Jan 12, 2017 |
NEUROCRINE BIOSCIENCES INC
|
CEO |
Sell |
45.0
|
-3,750
|
-1.53%
|
✓
|
$162.3K |